Inherited Abnormalities of Platelets clinical trials at UCSF
1 research study open to eligible people
open to all eligible people
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
Oakland, California and other locations
Our lead scientists for Inherited Abnormalities of Platelets research studies include Thomas Martin.